Last year, the president signed the Medicare Access & CHIP Reauthorization Act of 2015 (MACRA), which creates a new payment model for seasoned Medicare providers. Final rules are expected on November 1.
September 13, 2016 | Julie Miller, Editor in Chief
Commercial health insurers paid treatment centers and other providers $445.7 million to treat plan members’ opioid dependence and abuse in 2015, demonstrating a 1,375% spending increase over five years.
As part of a $300 million settlement, UnitedHealthcare will no longer require policyholders to demonstrate abstinence from drugs and alcohol for six months before receiving coverage for a costly hepatitis C medication.
The number of new coalitions and collaborations that have popped up just in the past year or so is a sure sign of everyone’s passion to make changes in how addiction treatment is delivered and how it is reimbursed.
For behavioral health providers, the most significant provision of the new rule allows Medicaid to pay for 15 days of inpatient treatment in a facility with more than 16 beds, tempering the often bemoaned IMD exclusion.